FDA Approved OrthoSensor’s Verasense for knee alignment
OrthoSensor Inc. has received FDA 510(k) clearance for its alignment capabilities with the Verasense Sensor-Assisted Technology to be used with the Zimmer Biomet Persona Knee implant system.

Verasense displays real-time data for surgeons during primary and revision total knee arthroplasty, according to the company press release.

Allowing for full range of motion while keeping optimal knee stability and implant alignment is paramount in TKAs, according to Martin Roche, MD, orthopedic surgeon and chief medical officer of OrthoSensor.
“The data that is provided from the single-use Verasense sensor will enable surgeons at hospitals and ambulatory surgery centers to make objective assessments intraoperatively of soft-tissue balance and knee alignment with the Persona implant system for the best possible patient outcomes,” Roche said in the release.

“This FDA clearance of our alignment technology for Verasense with Zimmer Biomet Persona is a great milestone for OrthoSensor,” Ivan Delevic, president and CEO of OrthoSensor Inc., said in the release. “OrthoSensor has always been committed to quantifying orthopedics through sensor-assisted technology and enable health care providers globally with evidenced-based treatments that improve clinical and economic outcomes for patients and health care stakeholders.”